I believe they will be great .It will cause this stock to at least double if not triple or more.
If Epratuzumab is approve I believe they could sell there rights to the drug for a billion cash.They have up to 300 mil milestone payment and about 19 percent royalties on net sale.Should be worth a billion easy.
I believe the results will be great and drug will be approved. Immu will not have money problems by then.
cisco a simalar thing happened to meI was buying hgsi human genom started buying at like 2.80 went down bought at 1.87 went down bought at .87 went down to like 48 cents.Then about a year later boom was selling at 13.50 then 18.00 then 28.00 and I was out.I bought Jazz during that time for 1 dollar and sold it for like 4 look where it is now like 150
Black cat my old Jewish friend use to say but high and sell low for what ever it's worth.Just a regular investor.
My belief is the lupus drug will be approved.The 3rd phase trails will be done in the 1st quarter of 2015.My belief is a milestone payment will be due then and after approval.The royalties should be like 190 million a year.So my belief is this could be about 15 a share by this time next year.
If I collect the dividend for 6 months and the stock goes up 20 cents just a rough guess thats like 12% per year I could live with that.Just a regular investor.
Iran said they would close the straights if attacked shutting down oils from going through there.This is a very real posibility.
U.S. Secretary of State Kerry leaves his plane at Vienna International Airport .
U.S. Secretary of State John Kerry leaves his plane at Vienna International Airport as he arrives for …
By John Irish and Lesley Wroughton
Iran says it will not 'kneel' as nuclear talks enter crunch time Reuters
Kerry to give troubled Iran nuclear talks a kick along AFP
Iran nuclear talks: 3 issues that must resolved for an accord this month Christian Science Monitor
Exclusive: Iran eases demands in Vienna nuclear talks - Western diplomats Reuters
Final push in 'historic' Iran nuclear talks AFP
VIENNA (Reuters) - U.S. Secretary of State John Kerry said on Sunday major differences persist between Iran and six world powers negotiating on Tehran's nuclear program, with a week to go before a deadline for a deal.
The United States, Britain, France, Germany, Russia and China want Iran to reduce its nuclear fuel-making capacity to deny it any means of quickly producing atom bombs. In exchange, international sanctions that have crippled the large OPEC member's oil-dependent economy would gradually be lifted.
Iran says it is enriching uranium for peaceful energy purposes only and wants the sanctions removed swiftly. But a history of hiding sensitive nuclear work from U.N. inspectors raised international suspicions and the risk of a new Middle East war if diplomacy fails to yield a long-term settlement.
"Obviously we have some very significant gaps still, so we need to see if we can make some progress," Kerry said ahead of meetings with foreign ministers who flew into the Austrian capital at the weekend to breathe new life into the talks.
Iranian Deputy Foreign Minister Abbas Araqchi delivered a similar message. He was quoted by Iran's Arabic language al-Alam television as saying that "disputes over all major and important issues still remain. We have not been able